Your session is about to expire
← Back to Search
This trial will study how to best help Emergency Department patients with AUD start on MAT, using oral naltrexone. They will split the patients into two groups and study how to best help them in each group.
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- You have been dependent on opioids (strong pain medications) in the past year.You have thoughts of hurting yourself or others.You are currently using or expect to need strong pain medications called opioids.
- Group 1: Oral Naloxone
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
In what ways can Emergency Department Initiated Oral Naltrexone help patients?
"Emergency Department Initiated Oral Naltrexone (EDION) is a recommended treatment for the alleviation of symptoms related to opioids, disease, and pain. It may also be used to address physical activity levels if necessary."
What objectives has this investigation endeavored to accomplish?
"The main aim of this 14-day study is to gauge the number of participants enrolled and receiving addiction treatment at day 30. Additional objectives include assessing adherence to daily oral naltrexone through pill counts, measuring alcohol cravings with a Qualtrics scale (0-36), and using GRIP guide - a self-reported questionnaire - to check adherence at Day 14."
Has the Federal Drug Administration authorized Emergency Department Initiated Oral Naltrexone?
"Due to the limited data concerning its efficacy and safety, Emergency Department Initiated Oral Naltrexone has been assigned a rating of 1 on our scale from 1-3."
How many participants are actively enrolled in this research endeavor?
"Absolutely. Clinicaltrials.gov displays that, since the original posting of this clinical trial on September 28th 2021, recruitment is still ongoing. 30 volunteers will be accepted at one centre for the study's duration."
Are individuals being sought for participation in this scientific investigation?
"Correct. As stated on clinicaltrials.gov, this medical trial is currently seeking participants since its inception on September 28th 2021 and last modification on February 11th 2022. The team needs to find 30 patients from a single site to complete the study's requirements."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends